Because HDAC inhibition stimulated pro-inflammatory responses in macrophages and enhanced anti-tumor immune responses to facilitate tumor regression, we speculated that the TAMs might act as mediators of the HDACi-elicited immunomodulatory activity. The gene discussed is HDAC9; the disease is neoplasm.